Overall survival results of ICON6: A trial of chemotherapy and cediranib in relapsed ovarian cancer

被引：11

作者：

Ledermann, Jonathan A.

Embleton, Andrew C.

Perren, Timothy

Jayson, Gordon C.

Rustin, Gordon J. S.

Kaye, Stanley B.

Hirte, Hal W.

Oza, Amit M.

Vaughan, Michelle Margaret

Friedlander, Michael

Martin, Antonio Gonzalez

Clark, Elizabeth

Popoola, Babasola

Farrelly, Laura

Swart, Ann Marie

Cook, Adrian

Kaplan, Richard S.

Parmar, Mahesh K. B.

机构：

[1] UCL, Inst Canc, London, England

[2] UCL, MRC Clin Trials Unit, London, England

[3] St James Univ Hosp, Leeds, W Yorkshire, England

[4] CRUK Manchester Inst, Manchester, Lancs, England

[5] Mt Vernon Hosp, Northwood, Middx, England

[6] Royal Marsden NHS Fdn Trust, Inst Canc Res, London, England

[7] Juravinski Canc Ctr, Hamilton, ON, Canada

[8] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada

[9] Christchurch Hosp, Christchurch, New Zealand

[10] Prince Wales Hosp, Randwick, NSW, Australia

[11] GEICO, Madrid, Spain

[12] MD Anderson Canc Ctr Madrid, Madrid, Spain

[13] UCL, Comprehens Clin Trials Unit, London, England

[14] CRUK, London, England

[15] UCL, Canc Trials Ctr, London, England

[16] Norwich Clin Trials Unit, Norwich, Norfolk, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷

关键词：

D O I：

10.1200/JCO.2017.35.15_suppl.5506

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5506

引用

页数：5